July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United... Nation’s 90-90-90 targets. In particular, the report synthesises the existing and emerging market demand and supply of kits.
The information in this report is intended for manufacturers, donors, national programmes, researchers and other global health stakeholders who are exploring the potential role of HIVST.
more
Health Systems in Transition. Vol. 5 No.3 2015
After almost eight bloody years, the war in Syria finally appears to be reaching the endgame. The Assad regime controls some two-thirds of the country. In the northwest, the regime of Syrian President Bashar al-Assad has launched an offensive against opposition-controlled Idlib governorate under the... cover of a brutal Russian bombing campaign. Upwards of 3 million Syrians in Idlib are under threat. Meanwhile, in northeast Syria, the Syrian Democratic Forces—the Syrian Kurdish dominated militia backed by the United States—have dislodged the Islamic State and now control one-third of the country. However, the humanitarian situation in the northeast remains extremely fragile and could deteriorate quickly. Indeed, over a third of the 4 million people in this area need humanitarian assistance and some 600,000 are displaced.
more
European Scientific Journal, November edition vol. 8, No.26 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431
Accessed: 29.09.2019
Q3: Can febrile seizures (simple or complex) be managed at first or second level care by non-specialist health care providers in low and middle income country settings? What is the role of diagnostic tests in the management of febrile seizures by non-specialists in low and middle income settings? Fo...r prophylaxis to prevent recurrence of simple or complex febrile seizures, which of the pharmacological interventions when compared with placebo/comparator produce benefit/harm in specified outcomes?
- continuous anticonvulsant therapy - intermittent anticonvulsant therapy - intermittent antipyretic treatment
more
Q5: What is the added advantage of doing an electroencephalography (EEG) in people with convulsive epilepsy in non- specialist settings in low and middle income countries?